Terms: = Cervical cancer AND KMT2D, ENSG00000167548, 8085, MLL2 AND Clinical Outcome
3 results:
1. Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy?
Kim H; Beriwal S; Houser C; Huq MS
Med Dosim; 2011; 36(2):166-70. PubMed ID: 20488690
[TBL] [Abstract] [Full Text] [Related]
2. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract] [Full Text] [Related]
3. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix.
Nag S; Erickson B; Thomadsen B; Orton C; Demanes JD; Petereit D
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):201-11. PubMed ID: 10924990
[TBL] [Abstract] [Full Text] [Related]